Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-up

Clinical Rheumatology

Volumn 28, Issue 8, 2009, Pages 947-953

  Ng, K P ^a   Ramos, F ^b   Sultan, S M ^a   Isenberg, D A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Auto immune; Concomitant disease; Damage; Inflammatory myositis

Indexed keywords

AZATHIOPRINE; CREATINE KINASE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOGLOBULIN; METHOTREXATE; RITUXIMAB; STEROID;

ABDOMINAL DISEASE; ADULT; ARM WEAKNESS; ARTICLE; AUTOIMMUNE DISEASE; BULBAR PARALYSIS; CARPAL TUNNEL SYNDROME; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CORTICOSTEROID THERAPY; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DIABETES MELLITUS; DISEASE COURSE; ENDOMETRIUM CARCINOMA; FATIGUE; FEMALE; FEVER; HEAD INJURY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IDIOPATHIC INFLAMMATORY MYOSITIS; INFECTION; KIDNEY FAILURE; LIMB WEAKNESS; LUNG DISEASE; LUNG FIBROSIS; MALE; MYOSITIS; OSTEOPENIA; OSTEOPOROSIS; POLYMYOSITIS; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RHEUMATIC DISEASE; SJOEGREN SYNDROME; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; MYOSITIS; OSTEOPOROSIS; PREDNISOLONE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 67849097324     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1181-4     Document Type: Article

References (39)

1. Ehrenstein MR, Snaith ML, Isenberg DA (1992) Idiopathic myositis: A rheumatological view. Ann Rheum Dis 51(1):41-44
2. Sultan SM, Ioannou Y, Moss K, Isenberg DA (2002) Outcome in patients with idiopathic inflammatory myositis: Morbidity and mortality. Rheumatology (Oxford) 41(1):22-26
3. Marie I, Hachulla E, Hatron PY et al (2001) Polymyositis and dermatomyositis: Short term and long term outcome, and predictive factors of prognosis. J Rheumatol 28(10):2230-2237
4. Ponyi A, Borgulya G, Constantin T, Vancsa A, Gergely L, Danko K (2005) Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis. Rheumatology (Oxford) 44(1):83-88
5. Airio A, Kautiainen H, Hakala M (2006) Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol 25(2):234-239
6. Torres C, Belmonte R, Carmona L et al (2006) Survival, mortality and causes of death in inflammatory myopathies. Autoimmunity 39(3):205-215
7. Maugars YM, Berthelot JM, Abbas AA, Mussini JM, Nguyen JM, Prost AM (1996) Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol 14(3):263-274
8. Tymms KE, Webb J (1985) Dermatopolymyositis and other connective tissue diseases: A review of 105 cases. J Rheumatol 12(6):1140-1148
9. Rios G (2005) Retrospective review of the clinical manifestations and outcomes in Puerto Ricans with idiopathic inflammatory myopathies. J Clin Rheumatol 11(3):153-156
10. Uthman I, Vázquez-Abad D, Senécal JL (1996) Distinctive features of idiopathic inflammatory myopathies in French Canadians. Semin Arthritis Rheum 26(1):447-458
11. McDonagh JE, Isenberg DA (2000) Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus. Ann Rheum Dis 59(3):230-232
12. Chambers SA, Charman SC, Rahman A, Isenberg DA (2007) Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality. Ann Rheum Dis 66(9):1173-1177
13. Lazarus MN, Isenberg DA (2005) Development of additional autoimmune diseases in a population of patients with primary Sjogren's syndrome. Ann Rheum Dis 64(7):1062-1064
14. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292(7):344-347
15. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292(8):403-407
16. Vitali C, Bombardieri S, Moutsopoulos HM et al (1993) Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 36(3):340-347
17. Clarke AE, Bloch DA, Medsger TA Jr, Oddis CV (1995) A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis. Arthritis Rheum 38(9):1218-1224
18. Bronner IM, van der Meulen MF, de Visser M et al (2006) Long-term outcome in polymyositis and dermatomyositis. Ann Rheum Dis 65(11):1456-1461
19. Marie I, Hachulla E, Cherin P et al (2002) Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 47(6):614-622
20. Selva-O'Callaghan A, Labrador-Horrillo M, Munoz-Gall X et al (2005) Polymyositis/dermatomyositis-associated lung disease: Analysis of a series of 81 patients. Lupus 14(7):534-542
21. Yaqub S, Moder KG, Lacy MQ (2004) Severe, reversible pulmonary hypertension in a patient with monoclonal gammopathy and features of dermatomyositis. Mayo Clin Proc 79(5):687-689
22. Grateau G, Roux ME, Franck N et al (1993) Pulmonary hypertension in a case of dermatomyositis. J Rheumatol 20(8):1452-1453
23. Kissel JT, Mendell JR, Rammohan KW (1986) Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 314(6):329-334
24. Wakata N, Kurihara T, Saito E, Kinoshita M (2002) Polymyositis and dermatomyositis associated with malignancy: A 30-year retrospective study. Int J Dermatol 41(11):729-734
25. Hill CL, Zhang Y, Sigurgeirsson B et al (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: A population-based study. Lancet 357(9250):96-100
26. Sigurgeirsson B, Lindelof B, Edhag O, Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326(6):363-367
27. Bernatsky S, Boivin JF, Joseph L et al (2005) An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 52(5):1481-1490
28. Bernatsky S, Clarke AE, Suissa S (2008) Haematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch Intern Med 168(4):378-381
29. Biro E, Szekanecz Z, Czirjak L et al (2006) Association of systemic and thyroid autoimmune diseases. Clin Rheumatol 25(2):240-245
30. Koh ET, Seow A, Ong B, Ratnagopal P, Tjia H, Chng HH (1993) Adult onset polymyositis/dermatomyositis: Clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis 52(12):857-861
31. Shamim EA, Miller FW (2000) Familial autoimmunity and the idiopathic inflammatory myopathies. Curr Rheumatol Rep 2(3):201-211
32. Marie I, Hachulla E, Cherin P et al (2005) Opportunistic infections in polymyositis and dermatomyositis. Arthritis Rheum 53(2):155-165
33. Viguier M, Fouere S, de la Salmoniere P et al (2003) Peripheral blood lymphocyte subset counts in patients with dermatomyositis: Clinical correlations and changes following therapy. Medicine (Baltimore) 82(2):82-86
34. Ishida Y, Utikoshi M, Kurosaki M et al (1998) Hepatic veno-occlusive disease in a case of polymyositis associated with thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Intern Med 37(8):694-699
35. Miller FW, Rider LG, Chung YL et al (2001) International Myositis Outcome Assessment Collaborative Study Group. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) 40(11):1262-1273
36. Isenberg DA, Allen E, Farewell V et al (2004) International Myositis and Clinical Studies Group (IMACS). International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 43(1):49-54
37. Sultan SM, Allen E, Oddis CV et al (2008) Reliability and validity of the myositis disease activity assessment tool. Arthritis Rheum 58(11):3593-3599
38. Shamim EA, Rider LG, Pandey JP et al (2002) Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican mestizos and North American Caucasians: Ethnogeographic influences in the genetics and clinical expression of myositis. Arthritis Rheum 46(7):1885-1893
39. O'Hanlon TP, Rider LG, Mamyrova G et al (2006) HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: Allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. Arthritis Rheum 54(11):3670-3681